Related Experiment Video

Updated: Feb 28, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.9K

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future

John P Veluchamy1,2, Nina Kok2, Hans J van der Vliet1

  • 1Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands.

Frontiers in Immunology
|June 17, 2017
PubMed

Insights

Allogeneic natural killer (NK) cells show promise in cancer immunotherapy, offering potential clinical benefits over autologous NK cells. Research focuses on optimizing NK cell platforms to enhance their anti-tumor functions.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Therapy

Background:

  • Natural killer (NK) cells are crucial immune cells for cancer defense.
  • NK cells in cancer patients are often dysfunctional and depleted.
  • Adoptive transfer of NK cells is a key strategy in cancer immunotherapy.

Purpose of the Study:

  • To compare the clinical benefits of allogeneic NK cells versus autologous NK cells.
  • To discuss current NK cell platforms for cancer immunotherapy.
  • To highlight strategies for augmenting NK cell function.

Main Methods:

  • Review of clinical studies on adoptive NK cell transfer.
  • Comparison of allogeneic and autologous NK cell therapy outcomes.
  • Analysis of NK cell platforms developed by biotech industries.

Main Results:

  • Early autologous NK cell therapies showed limited clinical benefit.
  • Allogeneic NK cell transfer demonstrates potential in both transplant and non-transplant settings.
  • Various biotech platforms are being developed to enhance NK cell efficacy.

Conclusions:

  • Allogeneic NK cells represent a promising avenue for cancer immunotherapy.
  • Optimizing NK cell function is critical for improving anti-tumor responses.
  • Further development of NK cell platforms is essential for clinical success.
Keywords:
adoptive natural killer cell therapyallogeneic natural killer cellsautologous natural killer cellshematopoietic stem cell transplantationnatural killer cell biotech companiesnatural killer cell combinatorial studies

More Related Videos

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

6.5K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

22.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.8K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
9.1K